Related Experiment Video

Updated: Nov 27, 2025

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice
08:40

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

18.0K

Mitophagy Receptors in Tumor Biology

Yangchun Xie1, Jiao Liu2, Rui Kang3

  • 1Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Cell and Developmental Biology
|December 2, 2020
PubMed

Insights

Mitophagy, the degradation of damaged mitochondria, is crucial in cancer. Autophagy receptors regulate this process, and their dysfunction impacts tumor growth and treatment response.

Area of Science:

  • Mitochondrial biology
  • Cellular degradation pathways
  • Cancer research

Background:

  • Mitochondria are vital organelles involved in energy production, macromolecule synthesis, and cell death regulation.
  • Understanding mitochondrial dynamics, including mitophagy, is key for developing novel anticancer strategies.
  • Mitophagy, a selective form of autophagy, removes damaged mitochondria, particularly under stress conditions like hypoxia and oxidative damage.

Purpose of the Study:

  • To review the latest advancements in mitophagy mechanisms.
  • To highlight the role of mitophagy receptors in cancer development and treatment.

Main Methods:

  • Literature review of current research on mitophagy.
  • Analysis of the function of autophagy receptors in mitochondrial degradation.
  • Examination of the dual role of mitophagy in tumorigenesis and cancer therapy.

Main Results:

  • Autophagy receptors, including mitochondrial proteins and lipids, mediate mitophagy in a context-dependent manner.
  • Dysfunctional mitophagy can either inhibit or promote tumor formation.
  • Mitophagy exhibits a dual role in the efficacy of chemotherapy, radiotherapy, and immunotherapy.

Conclusions:

  • Mitophagy receptors are critical regulators of mitochondrial quality control with significant implications in cancer.
  • Targeting mitophagy pathways and receptors presents a promising avenue for cancer treatment strategies.
  • Further research into mitophagy mechanisms is essential for advancing cancer therapy.
Keywords:
autophagycancercell deathmitochondriamitophagy

More Related Videos

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima09:13

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Published on: August 12, 2018

15.3K
Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome07:56

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome

Published on: November 30, 2022

5.5K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.3K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.5K